Overview
Adenoid cystic carcinoma of the corpus uteri (body of the uterus) is an extremely rare type of cancer that develops in the main body of the womb. This condition is classified as 'obsolete' in the Orphanet database, meaning it is no longer tracked as a separate disease entry, likely because it has been reclassified or merged into a broader category of rare uterine cancers. Adenoid cystic carcinoma (ACC) is a type of cancer more commonly found in the salivary glands, but it can very rarely occur in other parts of the body, including the uterus. When it does appear in the uterus, it tends to behave differently from the more common types of uterine cancer such as endometrial adenocarcinoma. Symptoms may include abnormal vaginal bleeding (especially after menopause), pelvic pain, unusual vaginal discharge, and a feeling of fullness or pressure in the pelvis. Because this cancer is so rare, there is no standardized treatment protocol specific to it. Treatment typically follows general principles used for other rare uterine cancers and may include surgery (such as hysterectomy), radiation therapy, and sometimes chemotherapy. The rarity of this condition means that most knowledge comes from individual case reports rather than large clinical studies, making it important for patients to seek care at specialized cancer centers with experience in rare gynecologic tumors.
Also known as:
Key symptoms:
Abnormal vaginal bleedingBleeding after menopausePelvic pain or pressureUnusual vaginal dischargeFeeling of fullness in the lower bellyPain during intercourseUnexplained weight lossFatigueDifficulty urinating or changes in bladder habitsLower back pain
Sporadic
Usually appears on its own, not inherited from a parent
Adult
Begins in adulthood (age 18 or older)
Treatments
No FDA-approved treatments are currently listed for OBSOLETE: Adenoid cystic carcinoma of the corpus uteri.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for OBSOLETE: Adenoid cystic carcinoma of the corpus uteri at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for OBSOLETE: Adenoid cystic carcinoma of the corpus uteri.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to OBSOLETE: Adenoid cystic carcinoma of the corpus uteri.
Community
No community posts yet. Be the first to share your experience with OBSOLETE: Adenoid cystic carcinoma of the corpus uteri.
Start the conversation →Latest news about OBSOLETE: Adenoid cystic carcinoma of the corpus uteri
1 articlesCaregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What stage is my cancer, and has it spread beyond the uterus?,What treatment plan do you recommend, and what are the goals of each treatment?,How experienced is your team with this very rare type of uterine cancer?,Are there any clinical trials available for adenoid cystic carcinoma?,What side effects should I expect from the recommended treatments?,How often will I need follow-up visits, and what will monitoring involve?,Should molecular or genetic testing be done on my tumor to look for targetable mutations?
Common questions about OBSOLETE: Adenoid cystic carcinoma of the corpus uteri
What is OBSOLETE: Adenoid cystic carcinoma of the corpus uteri?
Adenoid cystic carcinoma of the corpus uteri (body of the uterus) is an extremely rare type of cancer that develops in the main body of the womb. This condition is classified as 'obsolete' in the Orphanet database, meaning it is no longer tracked as a separate disease entry, likely because it has been reclassified or merged into a broader category of rare uterine cancers. Adenoid cystic carcinoma (ACC) is a type of cancer more commonly found in the salivary glands, but it can very rarely occur in other parts of the body, including the uterus. When it does appear in the uterus, it tends to beha
How is OBSOLETE: Adenoid cystic carcinoma of the corpus uteri inherited?
OBSOLETE: Adenoid cystic carcinoma of the corpus uteri follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does OBSOLETE: Adenoid cystic carcinoma of the corpus uteri typically begin?
Typical onset of OBSOLETE: Adenoid cystic carcinoma of the corpus uteri is adult. Age of onset can vary across affected individuals.